Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

FairPoint Communications Inc (FRP): Here’s How One Investment Fund’s Demands Could Drastically Boost This Stock

According to its bio, Maglan Capital is a debt-focused investment fund involved in “all parts of the distressed cycle.” Maglan’s distressed master fund made over 40% in 2012, and its primary investment goal is “to create value for investors by achieving superior, risk-adjusted returns through all market cycles, with a vigilant concentration on capital preservation.”

FairPoint Communications Inc (NASDAQ:FRP)

Earlier today, Insider Monkey received an e-mail from Maglan, mentioning that it has demanded the following conditions from FairPoint Communications Inc (NASDAQ:FRP) in a schedule 13D:

1.       The immediate commencement of a $1.50 annual dividend to shareholders, to establish a dividend program in-line with other industry participants and establish stability for the Company’s share price at a price above $15;

2.       A review of the Company’s sale process for the assets that comprise the “Telecom Group”- FairPoint’s non-core, legacy business which “generates really solid cash flow” and a piece of which was sold for more than 6x trailing EBITDA earlier this year; and

3.       A review of the Company’s growth capital expenditure budget and expense cutting strategy, to ensure that stockholder capital is being directed to those areas that offer the highest possible long-term return.

In a separate letter sent to FairPoint dated April 11th, 2013,
Maglan conveyed the nature of their schedule 13D, mentioning, “FairPoint’s stock trades at a significant discount to its peers- approximately at a 2x EV/EBITDA discount.”

The letter also mentioned the following:

Its share price is currently at approximately $7, in contrast to the $24 share price when it emerged from Chapter 11 in 2011. Moreover, according to the most recently reported short-interest data (for March 28, 2013), FairPoint has the nefarious distinction of having the highest short-interest ratio on NASDAQ (for any company with reasonable trading volume) with over 4.532 million shares short (26.1 million total float; by Maglan’s estimates, there is a lot less outstanding for borrow than the total float) and 80 days to cover. Shareholders have been patient with the company’s operational turnaround and have suffered because the Board has not been vigilant in protecting shareholder value.

In the letter, Maglan Capital explained, “Operationally, FairPoint Communications Inc (NASDAQ:FRP) has made enormous strides. The Company’s revenue is stabilizing and management expects it to begin to grow later this year.” Furthermore, the fund said “We note that, other than through Angelo Gordon & Co., the Board has de minimis ownership of the Company’s shares.”

The pièce de résistance (emphasis added):

All of this gives us serious concerns about the current Board’s sense of urgency and alignment of interests with the Company’s owners. We suspect that our concerns are shared by a number of other large stockholders, and are of the impression that there has been little action taken, despite these concerns having been voiced directly to members of the Board in the past. Accordingly, we believe that it is important that the Board bring focus and urgency to the implementation of potential value-creating initiatives.

“With revenue expected to grow this year and CapEx coming down, a dividend of $1.50 per annum will cost the company approximately $40 million- well within the range of comfort,” the letter added, also mentioning that a dividend would likely “substantially increase the cost to short the stock.”

This is an important point to make, and the rest of the details can be seen below:


Letter to FairPoint

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!